midnolin-proteasome通路的结构基础及其在抑制髓瘤中的作用
bioRxiv : the preprint server for biology
|March 3, 2025
概括
中诺林-蛋白酶体通路在没有泛化的情况下降解核蛋白质. 这项研究揭示了它的机制,并将米多诺林下调与多发性骨髓瘤存活率联系起来.
科学领域:
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- 密多林-蛋白酶体通路使核蛋白质不依赖于无所不在地降解,但其精确的机制尚不清楚.
- 了解这种途径对于破译核蛋白循环及其在疾病中的作用至关重要.
研究的目的:
- 阐明midnolin-proteasome通路的机械细节. 为了阐明midnolin-proteasome通路的机械细节.
- 在多发性骨髓瘤中研究midnolin下调的作用.
主要方法:
- 进行X射线晶体学以确定中诺林-蛋白酶组合物的结构.
- 生物化学试验分析蛋白质与蛋白质相互作用和酶活性.
- 细胞研究,以评估midnolin下调对髓瘤细胞的影响.
主要成果:
- 结构分析显示,蛋白质体子单元PSMD2/Rpn1和PSMD14/Rpn11的重定位用于midnolin识别和基质输入.
- PSMD2/Rpn1结合了midnolin核定位序列,将活动限制在核中.
- PSMD14/Rpn11以非酶的方式作用,将密多林基质定位为蛋白质体降解.
- 棉诺林降低调节促进IRF4表达,这对多发性髓瘤细胞存活至关重要.
结论:
- 这项研究揭示了中诺林-蛋白酶体通路的分子机制,突出了蛋白酶体组件的新功能.
- 棉诺林降低调节被确定为多发性骨髓瘤进展的关键驱动因素,通过稳定IRF4.
- 这些发现为多发性骨髓瘤提供了潜在的治疗点.
相关概念视频
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
The Proteasome
8.5K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
8.5K
The Intrinsic Apoptotic Pathway
5.9K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
5.9K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K


